M. Herman Chui

1.6k total citations
50 papers, 964 citations indexed

About

M. Herman Chui is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, M. Herman Chui has authored 50 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Reproductive Medicine, 15 papers in Oncology and 14 papers in Obstetrics and Gynecology. Recurrent topics in M. Herman Chui's work include Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Chromatin Remodeling and Cancer (5 papers). M. Herman Chui is often cited by papers focused on Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Chromatin Remodeling and Cancer (5 papers). M. Herman Chui collaborates with scholars based in United States, Canada and Denmark. M. Herman Chui's co-authors include Blaise Clarke, Tian‐Li Wang, Ie−Ming Shih, Ie‐Ming Shih, Patricia Shaw, L. Sylvia, C. Blake Gilks, A. Ayhan, Clarissa A. Cassol and Özgür Mete and has published in prestigious journals such as Cancer, Cancer Research and Scientific Reports.

In The Last Decade

M. Herman Chui

46 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Herman Chui United States 17 363 352 307 215 205 50 964
Cristina Pons Spain 17 337 0.9× 478 1.4× 299 1.0× 257 1.2× 326 1.6× 24 1.2k
Ana Velasco Spain 18 203 0.6× 473 1.3× 255 0.8× 246 1.1× 290 1.4× 43 1.1k
Suha Deen United Kingdom 19 303 0.8× 349 1.0× 307 1.0× 125 0.6× 131 0.6× 40 960
Andrew P. Sciallis United States 15 113 0.3× 225 0.6× 254 0.8× 121 0.6× 126 0.6× 39 770
Masako Ishikawa Japan 20 581 1.6× 751 2.1× 391 1.3× 335 1.6× 375 1.8× 94 1.5k
Jean‐Christophe Sabourin France 15 177 0.5× 492 1.4× 734 2.4× 124 0.6× 79 0.4× 29 1.4k
Ken Ueki Japan 16 231 0.6× 375 1.1× 223 0.7× 38 0.2× 207 1.0× 33 882
Federica Torricelli Italy 18 95 0.3× 471 1.3× 208 0.7× 64 0.3× 96 0.5× 80 1.0k
Sung‐Im Do South Korea 16 57 0.2× 399 1.1× 340 1.1× 127 0.6× 65 0.3× 84 913
Yuko Hosoe Japan 13 188 0.5× 326 0.9× 853 2.8× 93 0.4× 56 0.3× 21 1.3k

Countries citing papers authored by M. Herman Chui

Since Specialization
Citations

This map shows the geographic impact of M. Herman Chui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Herman Chui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Herman Chui more than expected).

Fields of papers citing papers by M. Herman Chui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Herman Chui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Herman Chui. The network helps show where M. Herman Chui may publish in the future.

Co-authorship network of co-authors of M. Herman Chui

This figure shows the co-authorship network connecting the top 25 collaborators of M. Herman Chui. A scholar is included among the top collaborators of M. Herman Chui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Herman Chui. M. Herman Chui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johannet, Paul, M. Herman Chui, Jason Konner, et al.. (2025). Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate. Gynecologic Oncology. 195. 173–179.
2.
Chui, M. Herman, Ryan Kahn, Sarah Chiang, et al.. (2025). Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation. Clinical Cancer Research. 31(14). 3084–3095.
3.
Chui, M. Herman, Qianqian Song, Yuchen Jiao, et al.. (2024). Early Genetic Divergence of High-Grade Carcinomas Originating from Low-Grade Serous Ovarian Neoplasms. Modern Pathology. 38(1). 100629–100629. 3 indexed citations
4.
Lumish, Melissa, M. Herman Chui, Qin Zhou, et al.. (2024). A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2). Gynecologic Oncology. 182. 75–81. 7 indexed citations
5.
Dopeso, Higinio, David N. Brown, Arnaud Da Cruz Paula, et al.. (2024). TROP2 as a novel target in uterine carcinosarcoma organoid models. Gynecologic Oncology. 190. S204–S204. 1 indexed citations
6.
Shen, Sherry, Weining Ma, David N. Brown, et al.. (2023). HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. Modern Pathology. 36(11). 100299–100299. 12 indexed citations
7.
Wang, Yeh, Christopher Douville, Yen‐Wei Chien, et al.. (2023). Aneuploidy Landscape in Precursors of Ovarian Cancer. Clinical Cancer Research. 30(3). 600–615. 7 indexed citations
8.
Chui, M. Herman, et al.. (2023). Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status. International Journal of Gynecological Pathology. 42(5). 472–481. 4 indexed citations
9.
Chui, M. Herman & Lora H. Ellenson. (2023). Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components. The American Journal of Surgical Pathology. 47(7). 756–765.
10.
Grisham, Rachel N., Beryl Manning‐Geist, & M. Herman Chui. (2023). The highs and lows of serous ovarian cancer. Cancer. 129(17). 2613–2620. 5 indexed citations
11.
Al-Rawi, Duaa H., Vicky Makker, Britta Weigelt, et al.. (2022). GermlineSMARCA4Deletion as a Driver of Uterine Cancer: An Atypical Presentation. JCO Precision Oncology. 6(6). e2200349–e2200349. 3 indexed citations
12.
Grisham, Rachel N. & M. Herman Chui. (2022). Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum. Current Oncology Reports. 24(11). 1549–1555. 6 indexed citations
13.
Boroujeni, Amir Momeni, Robert A. Soslow, Sarah Chiang, et al.. (2022). Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors. Modern Pathology. 35(11). 1684–1694. 7 indexed citations
14.
Ho, David Joon, M. Herman Chui, Chad Vanderbilt, et al.. (2022). Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation. Journal of Pathology Informatics. 14. 100160–100160. 21 indexed citations
15.
Chui, M. Herman, Amir Momeni Boroujeni, Diana Mandelker, Marc Ladanyi, & Robert A. Soslow. (2020). Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma. Modern Pathology. 34(2). 490–501. 24 indexed citations
16.
Chui, M. Herman, Natalie Erdmann, Rodger E. Tiedemann, et al.. (2019). Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma. Cancer Research. 79(21). 5536–5549. 15 indexed citations
17.
Park, Youngran, M. Herman Chui, Yohan Suryo Rahmanto, et al.. (2019). Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Clinical Cancer Research. 25(18). 5584–5594. 95 indexed citations
18.
Yen, Ting‐Tai, Tsutomu Miyamoto, Shiho Asaka, et al.. (2018). Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma. Gynecologic Oncology. 150(3). 426–431. 34 indexed citations
19.
Chui, M. Herman, Yihong Wang, Ren‐Chin Wu, et al.. (2014). Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma. Modern Pathology. 28(3). 437–445. 15 indexed citations
20.
Chui, M. Herman, Clarissa A. Cassol, L. Sylvia, & Özgür Mete. (2013). Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(5). 557–563. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Pons Breakdown of academic impact, for papers by Ana Velasco Breakdown of academic impact, for papers by Suha Deen Breakdown of academic impact, for papers by Andrew P. Sciallis Breakdown of academic impact, for papers by Masako Ishikawa Breakdown of academic impact, for papers by Jean‐Christophe Sabourin Breakdown of academic impact, for papers by Ken Ueki Breakdown of academic impact, for papers by Federica Torricelli Breakdown of academic impact, for papers by Sung‐Im Do Breakdown of academic impact, for papers by Yuko Hosoe
Rankless by CCL
2026